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Osteoblasts and endothelium constitute functional niches that support haematopoietic stem cells in mammalian bone marrow [1] [2] [3] . Adult bone marrow also contains adipocytes, the number of which correlates inversely with the haematopoietic activity of the marrow. Fatty infiltration of haematopoietic red marrow follows irradiation or chemotherapy and is a diagnostic feature in biopsies from patients with marrow aplasia 4 . To explore whether adipocytes influence haematopoiesis or simply fill marrow space, we compared the haematopoietic activity of distinct regions of the mouse skeleton that differ in adiposity. Here we show, by flow cytometry, colony-forming activity and competitive repopulation assay, that haematopoietic stem cells and short-term progenitors are reduced in frequency in the adipocyte-rich vertebrae of the mouse tail relative to the adipocyte-free vertebrae of the thorax. In lipoatrophic A-ZIP/F1 'fatless' mice, which are genetically incapable of forming adipocytes 5 , and in mice treated with the peroxisome proliferator-activated receptor-c inhibitor bisphenol A diglycidyl ether, which inhibits adipogenesis 6 , marrow engraftment after irradiation is accelerated relative to wild-type or untreated mice. These data implicate adipocytes as predominantly negative regulators of the bone-marrow microenvironment, and indicate that antagonizing marrow adipogenesis may enhance haematopoietic recovery in clinical bone-marrow transplantation.
At birth, haematopoietic red marrow occupies virtually the entirety of the bone-marrow space, but with age, non-haematopoietic fatty marrow gradually predominates 7 . This 'fatty degeneration' of the marrow is a dynamic and reversible process 8, 9 . To investigate whether marrow adipocytes influence haematopoiesis, we surveyed the mouse skeleton for bones that harbour fatty marrow under normal conditions. We found that the spine of adult mice manifests a proximal to distal gradient of bone-marrow adipocytes: thoracic vertebrae are virtually adipocyte-free, whereas vertebrae starting at the level of the third or fourth tail segments are highly adipocytic (Fig. 1a) . We isolated bone marrow from the thoracic and tail vertebrae of 12-week-old mice and quantified the haematopoietic stem-cell and short-term progenitor compartments both phenotypically and functionally (schema in Supplementary Fig. 1 ). Bone marrow from tail vertebrae contains only 25% as many CD45
1 haematopoietic cells per segment as thoracic bone marrow, thus confirming the reduced overall haematopoietic cellularity evident by histology (Fig. 1b and 
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2 (KLSF)), multipotent progenitors (MPPs), common myeloid progenitors (CMPs), granulocyte-macrophage progenitors (GMPs) and megakaryocyte-erythroid progenitors (MEPs) in these different regions of the spine 10 . The percentage of all progenitor classes was reduced 2-3-fold in the CD45 1 haematopoietic cells of adipocyte-rich bone marrow of the tail vertebrae compared with non-adipocytic bone marrow from the thoracic vertebrae ( Fig. 1c and Supplementary Fig. 2b) . Congruent with the fluorescence-activated cell sorting (FACS) phenotype data, long-term repopulating HSCs, shortterm repopulating progenitors, spleen colonies and methylcellulose colony-forming units (c.f.u.) were reduced 1.5-3-fold in adipocyterich bone marrow from tail vertebrae as compared with adipocyte-free bone marrow from the thoracic vertebrae ( Fig. 1d-f and Supplementary Fig. 2c ). These phenomena are neither due to age nor weight-bearing status, for we observed a similar reduction in the frequency of short-term progenitors in younger (4 week-old) and older mice (13 months), as well as in another consistently fatty yet weightbearing region of the mouse skeleton, the distal tibia ( Supplementary  Fig. 3a-f ). Reduced frequency of CMPs and primitive c.f.u. also accompany the increased bone-marrow adiposity of femurs from leptin-deficient obese mice ( Supplementary Fig. 4a-d) . Moreover, we found that bone-marrow-derived adipocytes reduce the expansion of haematopoietic cells in stromal transwell co-cultures, indicating that adipocytes release diffusible inhibitors of haematopoiesis ( Supplementary Fig. 5a-d) . We therefore conclude that adipocyterich marrow is associated with lower absolute levels and relative numbers of haematopoietic progenitors.
To investigate the mechanism of reduced haematopoietic activity of adipocytic bone marrow, we performed cell-cycle analysis of the progenitor compartments. In all cases, we found fewer progenitors in the replicating phases of the cell cycle (S/G2/M) within the adipocyterich bone marrow ( Fig. 1g and Supplementary Fig. 6a ). Early progenitors (HSC/MPP) presented no significant difference in their G0/ G1 ratio, whereas late progenitors (GMP/CMP/MEP) presented a significant increase in the G0/G1 ratio ( Supplementary Fig. 6b ). To determine if the slow-cycling HSCs within the tail bone marrow were functional, as opposed to senescent, we FACS-sorted HSCs (KLSF) and transplanted them competitively into lethally irradiated mice. We observed no difference in repopulating activity between HSCs from tail and thorax in the first month after transplant. However, multilineage long-term engraftment was significantly higher in HSCs purified from tail bone marrow (Fig. 1h) , indicating that the slowcycling progenitors in adipocytic tail bone marrow are relatively quiescent and not senescent. This is consistent with the relative predominance of CD34 low HSCs within the KLSF fraction of tail bone marrow (Fig. 1i) , a phenotype associated with long-term repopulation activity 11 . Taken together, our data establish tail vertebrae as a model for the study of fatty marrow in the mouse, and demonstrate that adipocyte-rich marrow manifests altered haematopoiesis. HSCs and short-term progenitors are functionally reduced on a per cell basis in fatty marrow owing to reduced cycling at the level of the HSC, MPP and CMP compartments.
To determine whether the association between adipocytic marrow and reduced haematopoietic progenitor frequency is purely correlative, or whether adipocytes actively compromise haematopoiesis, we studied the lipoatrophic 'fatless' A-ZIP/F1 mouse, which cannot form adipocytes owing to the expression of a dominant-negative form of C/EBP under the adipocyte fatty-acid-binding protein 4 (Fabp4, also called aP2) promoter 5 . In contrast to wild-type mice, we found that the absence of adipocytes in fatless A-ZIP/F1 mice rescued haematopoiesis in the tail, such that A-ZIP/F1 mice presented no significant difference in the frequency of c.f.u. from thorax or tail bone marrow ( Supplementary Fig. 7a , b), indicating that compromised osteogenesis due to the non-weight-bearing nature of these bones cannot explain the haematopoietic defect of wild-type, adipocyte-rich tail vertebrae 12 . Notably, although fatless A-ZIP/F1 mice are diabetic, their blood counts were similar to controls during homeostasis, and their femoral bone marrow showed no competitive advantage over bone marrow from wild-type littermates, arguing that the diabetic environment does not account for the observed alterations in the haematopoietic compartment ( Supplementary  Fig. 8a-c) . We therefore conclude that the presence of adipocytes is necessary to observe reduced haematopoiesis in adipocyte-rich tail bone marrow.
We then analysed the effect of adipocytes on haematopoietic recovery after bone-marrow transplantation. Between the second and fourth week after lethal irradiation, the bone-marrow space throughout the mouse skeleton is replaced by adipocytes. During this post-transplant period mice (and human patients) depend on fast-cycling, short-term haematopoietic progenitors to rescue their otherwise lethal pancytopaenia 13 . Given our previous data, we predicted that the compromised adipogenesis in the A-ZIP/F1 mouse would enhance haematopoietic recovery in the post-transplant period through increased proliferation of short-term progenitors. We transplanted wild-type bone marrow (CD45.2) into either wild-type or fatless A-ZIP/F1 littermates (CD45.1, Fig. 2a ). In contrast to control mice, A-ZIP/F1 fatless mice exposed to lethal doses of irradiation produced markedly fewer adipocytes in the marrow cavity (Fig. 2b) . We monitored leukocyte recovery in the post-transplant period and found that recovering A-ZIP/F1 fatless mice have up to four times higher leukocyte counts in peripheral blood relative to their wild-type controls (Fig. 2c) . We also observed significantly accelerated recovery in the haemoglobin content of peripheral blood (Fig. 2d) . Importantly, both wild-type and A-ZIP/F1 fatless recipients showed comparable high-level long-term donor chimaerism after the primary transplant (Supplementary Fig. 8d ). In the third week after transplant, we recovered the donor CD45.2 bone marrow from the adipocyte-rich wild-type or the adipocyte-free AZIP/F1 femurs. We found a pronounced increase in haematopoietic progenitors in the recovering CD45.2 bone marrow isolated from fatless A-ZIP/F1 mice as determined by flow cytometry (Fig. 2e) , methylcellulose colony forming assays (Fig. 2f and Supplementary Fig. 8e ) and short-term competitive repopulation into secondary recipients (Fig. 2g) . Collectively, these results indicate that the lack of adipogenesis in A-ZIP/F1 recipient mice enhances haematopoietic recovery after lethal irradiation by enhancing engraftment of short-term progenitors, and further supports the conclusion that adipocytes in fatty marrow hinder haematopoietic progenitor expansion.
During our studies, we observed that bone-marrow ablation in lethally irradiated A-ZIP/F1 fatless mice was accompanied by marked osteogenesis. Trabecular bone was increased in the femurs of transplanted A-ZIP/F1 fatless mice compared to wild-type controls (Fig. 3a) , a phenomenon also apparent in the tail and in mice that were lethally ablated but received no transplant ( Supplementary Fig.  9a-c) . High-resolution micro-computerized tomography (mCT) confirmed a fivefold increase in trabecular bone that was specific to fatless A-ZIP/F1 mice after bone-marrow transplantation (Fig. 3a-c) . Incorporation of 18 F measured by micro-positron emission tomography (mPET) confirmed an increased bone metabolism, indicating new bone deposition in tails and tibias after bone marrow transplantation that was maximal in the second week after transplant (Fig. 3d, e) . Our data show that simultaneous ablation of the haematopoietic and bone-marrow adipocyte compartment can induce osteogenesis, which, as shown by others, promotes a more supportive environment for haematopoietic reconstitution that could explain the positive effect of adipocyte ablation in bone-marrow engraftment 1,2 . Our observation is compatible with a previous report that surgical removal of the fatty marrow in rabbit tibias induces transient haematopoietic infiltration and new osteoid and trabecular bone formation 14 . In addition to creating an osteogenic environment, fatless A-ZIP/F1 mice may accumulate mesenchymal elements that support haematopoietic recovery, or may be deficient in osteoclast elements that would antagonize trabecular bone growth during the recovery phase of lethal irradiation. Importantly, preventing the formation of bone-marrow adipocytes alone does not cause osteogenesis 15 , indicating that osteogenesis requires simultaneous ablation of both the adipocytic and haematopoietic compartments. These data suggest a three-way co-regulation of haematopoiesis, osteogenesis and adipogenesis within the bone-marrow compartment.
Finally, we tested whether blocking adipogenesis pharmacologically could enhance bone-marrow engraftment in wild-type mice. The peroxisome proliferator-activated receptor-c (PPAR-c) inhibitor bisphenol A diglycidyl ether (BADGE) has been shown to prevent bone marrow adipocyte formation in vitro and in vivo in models of streptozotocin-induced diabetes 6, 15 . Importantly, BADGE does not enhance haematopoietic colony formation in vitro, when bonemarrow cells are isolated from their stromal microenvironment (Supplementary Fig. 10 ). We administered BADGE to lethally LETTERS irradiated mice for the 2 weeks after bone-marrow transplantation, and observed successful inhibition of bone-marrow adipocyte formation (Fig. 4a) , higher peripheral blood leukocyte counts (Fig. 4b) and an enrichment in c.f.u. (Fig. 4c) . Our results demonstrate that the negative influence of adipocytes on post-transplant haematopoietic engraftment can be overcome pharmacologically, and suggest that PPAR-c inhibitors, or other adipocyte inhibitors such as the novel Fabp4 inhibitor BMS309403 (ref. 16 ), might serve as adjuvants to haematopoietic recovery in clinical bone-marrow transplantation.
Collectively, our results contradict the classical dogma that adipocytes act as passive space fillers in the marrow. We demonstrate that adipocyte-rich marrow harbours a decreased frequency of progenitors and relatively quiescent stem cells. Moreover, we observe that mice that are genetically deficient in adipogenesis show accelerated haematopoietic recovery after bone-marrow ablation, a phenomenon that can be reproduced pharmacologically in wild-type mice through PPAR-c inhibition. These results suggest a novel therapeutic approach to enhance haematopoietic engraftment after marrow or cord blood transplantation, or to ameliorate aplasia in genetic bone-marrow failure syndromes. Furthermore, our results suggest a plausible mechanism for the reports of myelosuppression [17] [18] [19] in patients treated with the PPAR-c agonist rosiglitazone, a diabetes drug known to increase marrow adiposity 20 . Our data indicate a predominantly suppressive influence of adipocytes on haematopoiesis within the bone-marrow microenvironment. Bone-marrow adipocytes are less supportive of haematopoiesis in vitro than their undifferentiated stromal or pre-adipocytic counterparts, in part due to reduced production of growth factors such as granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) 21, 22 . Moreover, adipose tissue secretes neuropillin-1 (ref. 23) , lipocalin 2 (refs 24, 25) , adiponectin 26 and TNF-a 27, 28 , each of which can impair haematopoietic proliferation. Of note, TNF-a and adiponectin inhibit progenitor activity while positively influencing the most primitive HSCs 27, 29 , suggesting that adipocytes prevent haematopoietic progenitor expansion while preserving the haematopoietic stem-cell pool. Adipocytes and osteoblasts originate from mesenchymal stem cells within the bone marrow, where both compartments hold a reciprocal relationship 30 . Balancing the supportive role of the osteoblast in the HSC niche, our data implicate adipocytes as negative regulators of haematopoiesis. Further studies will address the molecular players involved in the haematopoietic inhibition imposed by fatty marrow.
METHODS SUMMARY
Thorax, tibias and tails were isolated from wild-type C57BL6/J mice. B6.SJLPtprca Pep3b/BoyJ mice were used as bone-marrow donors to exploit the CD45.1/CD45.2 allelic system (Jackson Laboratories 0002014). Bone-marrow transplantation and c.f.u. spleen assays were performed on lethally irradiated mice (two 5.5-Gy doses separated by 3 h) and cells were administered by tail vein injection within 24 h of lethal irradiation. For competitive transplantation, samples were competed against 250,000 recipient-matched competitor femoral bone marrow cells. 
P r et r a n s p la n t T ib ia T a il P r et r a n s p la transplanted into FVB (CD45.1) recipients together with 250,000 FVB (CD45.1) wild-type competitor bone-marrow cells. For pharmacological inhibition of adipocyte formation, bone-marrow transplants were performed in wild-type female FVB mice as described above, except that 30 mg kg 21 BADGE or control vehicle (DMSO 10%) were administered in daily intraperitoneal injections starting 1 day before irradiation and continuing until day 14 after transplant. A total of 500 mg BADGE (Fluka) was re-suspended in 8.3 ml DMSO (Sigma) and diluted in PBS to a final concentration of 10% DMSO for administration at 30 mg kg 21 in 100 ml. Aliquots were stored at 220 uC and thawed daily. Multicolour flow cytometry was performed in a BD five-laser LSRII flow cytometer. Cell cycle analysis was performed with DAPI (Sigma) in cells fixed in 2% paraformaldehyde for 15 min at 4 uC. For all statistical analyses an unpaired two-tailed Student's t-test was performed assuming equal variance of samples. Error bars and confidence intervals represent the standard error of the mean (s.e.m.) unless otherwise indicated.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
